World AIDS Day 2025 - Q&A with Dr. Robert Paulino-Ramírez

Dr. Robert Paulino-Ramírez, an Editorial Board Member of BMC Global and Public Health, discusses the challenges faced by vulnerable populations with AIDS, and expresses his goal of achieving a more compassionate healthcare system through his research in HIV prevention and stigma reduction.
World AIDS Day 2025 - Q&A with Dr. Robert Paulino-Ramírez
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

About the Researcher

Dr. Robert Paulino-Ramírez is a Dominican physician–scientist specializing in infectious diseases, molecular microbiology, and public health. He earned his MD degree from the Universidad Autónoma de Santo Domingo in the Dominican Republic, and completed postgraduate studies in microbiology, public health, and epidemiology. He pursued fellowship training in Infectious Diseases and HIV at Weill Cornell Medical College in New York, and holds professional diplomas in Tropical Medicine and Hygiene from the London School of Hygiene & Tropical Medicine, as well as in Emerging Viral Pathogens and Biosafety Level 4 Unit Management from the Universidad Autónoma de Madrid, Spain.
He currently serves as Professor of Tropical Medicine, Global Health, and Medical Microbiology at Universidad Iberoamericana (UNIBE) and as Clinical Associate Professor at Michigan State University. A former Director and Principal Investigator of UNIBE’s Institute of Tropical Medicine & Global Health, his research centers on HIV/AIDS, sexually transmitted infections, and emerging infectious diseases.

How does your research relate to the SDGs?

My research aligns closely to the Sustainable Development Goals (SDGs), particularly 3, 10 and 17, which are aimed to advocate for good health and well-being, reducing inequalities, and establishing partnerships for the goals. Through studies on HIV prevention, stigma reduction, and access to care among vulnerable populations, I aim to strengthen equitable health systems and advance the UNAIDS 95-95-95 targets, focused in LMIC countries. Our implementation projects, such as stigma-reduction interventions (FRESH and its Spanish version CREEV), PrEP/PEP/DoxyPEP adoption studies, and evaluations of diagnostic innovations for HIV and TB, contribute to reducing health inequities and promoting universal access to quality healthcare.

Why did you decide to go into your field of research?

I chose to focus on HIV and infectious diseases because they reveal the profound intersection between biology, social justice, and human dignity. Early in my medical training, I witnessed how stigma, misinformation, and systemic barriers could be as harmful as the virus itself. This realization inspired me to pursue research that not only improves diagnostics and prevention tools, but also transforms the way healthcare systems treat people—with respect, compassion, and evidence-based care.

How has knowledge of HIV and AIDS developed over the course of your career?

When I began my career, HIV research in the Caribbean primarily focused on treatment access, and epidemiological studies to untangle the epidemic. Over time, the field has evolved to include implementation science, behavioral and structural determinants, and community engagement as essential pillars of the response. We now understand that ending the HIV epidemic requires integrating biomedical advances, what we called an “HIV Toolbox”—such as PrEP, PEP and recently the scientific breakthrough in HIV prevention; the long-acting ART—along with social interventions that address stigma, gender inequities, and mental health. The shift from a purely clinical model to a people-centred and equity-driven approach has been transformative.

What challenges do those from low- and middle-income countries in particular face?

One of the main challenges, and in my opinion the most crucial, is the lack of research funding. Research in most Latin American countries is still seen as a luxury, not a necessity. Many researchers in the Global South have to rely on external funding mechanisms that don't always reflect local needs and don't close the existing knowledge gap in those regions. There is also the persistent issue of brain drain and insufficient local research capacity. Moreover, community mistrust in science and health leaders, stigma, and structural inequalities—rooted in poverty and discrimination—continue to undermine HIV prevention and care. Despite these barriers, local innovation and resilience have driven remarkable progress, particularly through South-South collaborations and community-based approaches.

What are your hopes for progress in the future?

My hope is that we can have a future where we eliminate HIV, but first we must ensure that people have access to life-saving treatments. Even though programs offer these treatments, the stigma is still so intersecting that even healthcare providers don't realize its impact. A world where we can work alongside communities to provide answers to their needs—nothing about them without them. I envision a new generation of regional researchers leading locally driven studies, ensuring that evidence from the Global South informs global policy. Ultimately, the goal is not only to end the HIV epidemic but also to build more just, inclusive, and compassionate health systems that reflect the dignity of every person.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

AIDS
Humanities and Social Sciences > Society > Sociology > Health, Medicine and Society > HIV infections > AIDS
Global Health
Humanities and Social Sciences > Society > Sociology > Health, Medicine and Society > Global Health
Public Health
Life Sciences > Health Sciences > Public Health
HIV infections
Life Sciences > Health Sciences > Clinical Medicine > Diseases > Infectious Diseases > HIV infections
SDG 3: Good Health & Wellbeing
Research Communities > Community > Sustainability > UN Sustainable Development Goals (SDG) > SDG 3: Good Health & Wellbeing

Related Collections

With Collections, you can get published faster and increase your visibility.

Ensuring continuity of care in LMICs

BMC Global and Public Health is calling for submissions to our Collection on ensuring continuity of care in low- and middle-income countries (LMICs). In the realm of global health, one of the persistent challenges facing LMICs is ensuring the delivery of integrated, coordinated, and continuous care across healthcare services. The concept of seamless care is paramount, aiming to guarantee that individuals receive integrated and coordinated healthcare across different levels of the healthcare system and over time. This Collection seeks to shed light on innovative strategies, research findings, and practical solutions in LMICs.

We invite contributions that explore various dimensions of integrated, coordinated and continuous care of care in LMICs, including but not limited to:

Health System Strengthening: Investigations into approaches for strengthening health systems in LMICs to support seamless access to healthcare services. This may include efforts to improve infrastructure, enhance workforce capacity, and optimize service delivery models.

Integrated Care Models: Exploration of integrated care approaches that facilitate collaboration among diverse healthcare providers, services, and institutions. These models aim to improve care coordination, referrals, and counter-referrals, reduce fragmentation, and enhance the patient experience.

Digital Health Solutions: Assessments of the role of digital health technologies in enhancing continuity of care in LMICs. This may include the use of electronic health records, telemedicine, mobile health applications, AI, and other innovative digital tools to overcome barriers to access and improve healthcare delivery.

Community-Based Care: Studies on community-based healthcare initiatives that empower communities to take ownership of their health and well-being. These initiatives often play a crucial role in ensuring ongoing access to essential healthcare services, particularly in remote or underserved areas.

Policy and Governance: Examination of policy and governance frameworks aimed at promoting continuity of care in LMICs. This may include analyses of healthcare financing mechanisms, regulatory frame.

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being by advancing our understanding of continuity of care and contributing to efforts to ensure equitable access to quality healthcare services for all populations, regardless of geographical location or socioeconomic status.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Apr 23, 2026

Infectious disease modeling: Impact on public health practices

BMC Global and Public Health is calling for submissions to our Collection on innovative approaches that advance our understanding of health issues impacting communities worldwide. This Collection will serve as a forum for sharing research that improves our ability to respond to critical challenges in disease control and prevention, fostering resilience in health systems and enhancing public health preparedness.

The aim of this Collection is to explore the dynamic field of infectious disease research and the critical insights it provides for effective public health interventions. We seek original studies, reviews, and case reports that shed light on how predictive methods and analyses can inform decision-making and improve health outcomes. Potential topics include, but are not limited to:

• Use of mathematical and statistical approaches to simulate disease transmission

• Novel methods for forecasting and early warning systems for disease outbreaks

• Evaluating the impact of vaccination and other preventive measures on disease dynamics

• Analysis of vector-borne disease spread and control strategies under changing environmental conditions

• Integration of socioeconomic and demographic factors in risk assessment models

• Machine learning and AI applications in infectious disease prediction

• Incorporating One Health perspectives to understand zoonotic transmission risks.

We encourage work from local, regional, national, and global partnerships and collaboration among multidisciplinary scientists using multiple methodologies. We ask that authors be careful to use non-stigmatizing/preferred language in their manuscripts as outlined in relevant language guidelines for their respective fields.

Contributions to this Collection will provide valuable insights to guide policy-making and practical solutions in public health. We invite researchers, practitioners, and policymakers to share evidence that advances our understanding of how to better predict and mitigate the impact of infectious diseases on populations, especially those disproportionately affected by health inequities.

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Apr 23, 2026